Diabetes Digital Therapeutics Market
Every Market-Reports.com study delivers in-depth market sizing, growth forecasts, competitive intelligence, segmentation analysis, and regional insights — built from company filings, government statistics and trade data, and structured for confident strategic decision-making. Request a free report preview to see its scope, chapters and methodology before you buy.
Market Snapshot
2025 Market Size
US$ 2.1 billion
Estimated Base Value
2035 Forecast
US$ 12.1 billion
Projected Market Value
CAGR 2026–2035
19.1%
Compound Annual Growth
Largest Segment
Prescription Digital Therapeutics
Fastest Growing Segment
Electric Commercial Vehicles
Leading Region
North America
Fastest Growing Region
Asia Pacific
Top Country
United States
By Market Share
Largest market
Key Players
Virta Health
Emerging Players
BeatO, Holmusk
Diabetes Digital Therapeutics Market Overview
The Diabetes Digital Therapeutics market comprises software-driven interventions and platforms designed to prevent, manage, or treat diabetes and its related complications. These evidence-based digital solutions, delivered via mobile applications, web platforms, or integrated with connected devices, aim to modify patient behavior, improve medication adherence, optimize glucose control, and provide personalized coaching and education. This market specifically covers clinically validated programs targeting Type 1, Type 2, prediabetes, and gestational diabetes, focusing on improving health outcomes through digital means. Buyers include patients and caregivers, hospitals and clinics, employers and payers, and pharmaceutical and medical device companies.
The Diabetes Digital Therapeutics market is estimated at $2.1 Bn in 2025 and is forecast to reach $12.1 Bn in 2035, growing at a CAGR of 19.1% between 2025 and 2035. This growth is driven by the increasing global prevalence of diabetes and the demand for convenient, accessible, and personalized care. Rapid technological advancements in mobile health and data analytics also contribute. However, reimbursement challenges, ensuring long-term patient engagement, and complex regulatory pathways present restraints to market expansion.
The market is segmented by Type (Prescription Digital Therapeutics, Non-Prescription Digital Therapeutics), Application (Type 1 Diabetes Management, Type 2 Diabetes Management), Technology (Artificial Intelligence & Machine Learning, Cloud-Based Platforms), End-User (Patients & Caregivers, Hospitals & Clinics), Deployment (Cloud-Based Software as a Service, On-Premise Software), and Functionality (Glucose Monitoring & Tracking, Medication & Insulin Management). Key regions include North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Leading companies include Virta Health, Omada Health, One Drop, and DarioHealth. The full report provides detailed analysis across these segments and regions, offering insights into market dynamics and competitive landscape.
Market Definition & Overview
The Diabetes Digital Therapeutics Market encompasses software-driven interventions and platforms designed to prevent, manage, or treat diabetes and its related complications. These evidence-based digital solutions, often delivered via mobile applications, web platforms, or integrated with connected devices, aim to modify patient behavior, improve medication adherence, optimize glucose control, and provide personalized coaching and education. This market specifically covers clinically validated programs targeting Type 1, Type 2, prediabetes, and gestational diabetes, focusing on improving health outcomes through digital means within the broader digital medicine and healthcare services industry.
Scope
- Global coverage, with detailed analysis for major regions including North America, Europe, and Asia Pacific
- Segmentation by diabetes type (Type 1, Type 2, Prediabetes), product type (prescription vs. non-prescription), and end-user
- Analysis period covering historical data, current market estimates, and a five-to-10-year forecast
Inclusions
- Prescription Digital Therapeutics (PDT) specifically for diabetes management
- Mobile applications offering behavioral change programs and glucose monitoring for diabetes
- Web-based platforms providing personalized diabetes coaching and education
- Integrated digital programs facilitating medication adherence and insulin dosage adjustments
- Connected devices (e.g., smart glucose meters) with integrated digital therapeutic components
- AI-driven algorithms for personalized insights and recommendations in diabetes care
Exclusions
- Traditional medical devices for diabetes (e.g., standalone insulin pumps, BGM devices) without digital therapeutic integration
- General health and wellness applications not specifically tailored for diabetes management
- Telehealth services focused purely on virtual doctor consultations without a structured digital therapeutic program
- Pharmaceutical drugs or insulins for diabetes treatment
- Hospital or clinic-specific Electronic Health Records (EHR) systems
Market Size Forecast
Executive Summary
• The Diabetes Digital Therapeutics market is valued at $2.1 Bn in 2025 and is forecast to reach $12.1 Bn by 2035, reflecting a robust CAGR of 19.1% as demand accelerates across every major segment and region over the ten-year outlook.
• Prescription Digital Therapeutics leads the segment breakdown by current market share, underscoring where the bulk of near-term revenue and competitive activity within this market is concentrated today.
• North America commands the largest regional share at XX.X%, while Emerging Areas is expanding the fastest at a XX.X% CAGR, signalling where future growth is shifting.
• United States remains the single largest country-level market at XX.X% of global share, anchoring overall demand within its home region throughout the forecast period.
• Intense competitive dynamics are fueling strategic partnerships and M&A, as established healthcare players and tech giants vie for market leadership in integrated diabetes management platforms.
• The accelerating shift towards value-based care models, coupled with increasing chronic disease prevalence and remote patient monitoring mandates, represents a powerful catalyst for DDT adoption globally.
• Advanced AI and machine learning integration, alongside evolving regulatory frameworks and clearer reimbursement pathways, are rapidly accelerating the clinical validation and market penetration of sophisticated DDT solutions.
• While North America remains the primary adoption hub, significant growth is anticipated across European and APAC markets, driven by increasing Type 2 diabetes prevalence and localized digital health infrastructure investments.
• Sustained robust venture capital and strategic corporate investments are fostering continuous innovation, particularly in predictive analytics and personalized intervention, crucial for long-term supply chain resilience and market leadership.
• The market is poised for a significant evolution towards integrated chronic care platforms, moving beyond standalone solutions to offer holistic, preventative, and personalized diabetes management across diverse patient populations.
Key Market Takeaways
Critical findings and data points from this market research study.
Current Market Value
The Diabetes Digital Therapeutics Market was valued at $2.1 billion in the base year.
Projected Market Surge
The market is projected to reach a substantial $12.1 billion by the forecast year.
High Growth Trajectory
This expansion signifies an impressive Compound Annual Growth Rate (CAGR) of 19.1% over the forecast period.
Exponential Market Growth
From a $2.1 billion valuation in the base year, the market is expected to achieve a significant $12.1 billion by the forecast year.
North American Dominance
North America is anticipated to maintain its leadership position due to high adoption rates of digital health solutions and substantial healthcare expenditure.
Personalized Care Adoption
A notable trend driving market expansion is the increasing demand for personalized digital therapeutics leveraging AI for tailored diabetes management.
Market Dynamics
Market Trends
- Rising adoption of AI and machine learning for personalized diabetes care.
- Increased shift towards remote patient monitoring and virtual care solutions.
- Growing integration of wearables and IoT devices for continuous data.
- Emphasis on holistic health and behavioral change programs.
Growth Drivers
- Increasing global prevalence of both Type 1 and Type 2 diabetes.
- High costs of traditional diabetes management are pushing digital solutions.
- Growing demand for convenient, accessible, and personalized care.
- Rapid technological advancements in mobile health and data analytics.
Restraints
- Reimbursement challenges limit market adoption and widespread access.
- Ensuring long-term patient engagement and adherence remains difficult.
- Complex regulatory pathways hinder rapid product development and launch.
- Data privacy and security concerns deter widespread user trust.
Opportunities
- Expansion into new geographic markets and underserved patient segments.
- Development of specialized solutions for specific diabetes types or comorbidities.
- Integration with broader healthcare systems and electronic health records.
- Focus on pre-diabetes management and prevention programs.
Market Dynamics Framework · 2026–2035
Need Custom Data for This Market?
Get tailored segmentation, deeper competitive intelligence, or region-specific deep dives from our analyst team.
Market Segmentation
| Segment | Sub-segments |
|---|---|
| By Type | Prescription Digital TherapeuticsNon-Prescription Digital TherapeuticsDigital Diabetes Management PlatformsDigital Coaching & Engagement PlatformsRemote Monitoring & Alert Systems |
| By Application | Type 1 Diabetes ManagementType 2 Diabetes ManagementPre-Diabetes Management & PreventionGestational Diabetes ManagementDiabetes Complications ManagementInsulin Titration & Dosing SupportWeight Management for Diabetes |
| By Technology | Artificial Intelligence & Machine LearningCloud-Based PlatformsMobile ApplicationsWearable & Sensor Technology IntegrationData Analytics & Visualization ToolsGamification & Behavioral ScienceSecure Communication & Interoperability Solutions |
| By End-User | Patients & CaregiversHospitals & ClinicsEmployers & PayersPharmaceutical & Medical Device CompaniesIndividual Healthcare Providers |
| By Deployment | Cloud-Based Software as a ServiceOn-Premise SoftwareHybrid Cloud |
| By Functionality | Glucose Monitoring & TrackingMedication & Insulin ManagementBehavioral & Lifestyle CoachingEducational & Self-Management ToolsRemote Patient Monitoring & AlertsPersonalized Feedback & GamificationData Analytics & ReportingInteroperability With Electronic Health Records |
Regional Analysis
- North America leads the diabetes digital therapeutics market due to high diabetes prevalence, significant healthcare expenditure, and advanced technological infrastructure. Favorable reimbursement policies and strong consumer adoption of digital health solutions further drive its dominance in this sector.
- Asia-Pacific is the fastest-growing region, driven by its vast population, increasing diabetes incidence, and improving digital health literacy. Government initiatives promoting digital healthcare and rising disposable incomes are fueling rapid market expansion here.
- In Europe, a significant trend is the increasing focus on regulatory clarity and reimbursement pathways for digital therapeutics, particularly under new MDR regulations. This is fostering greater market access and adoption, making real-world evidence crucial for success.
| North AmericaXX.X% | EuropeXX.X% | Asia PacificXX.X% | Latin AmericaXX.X% | Middle East & AfricaXX.X% |
North America
XX.X% CAGR
US$ XX.X Mn
XX.X% share
- This region leads the market due to robust healthcare infrastructure, high technology adoption rates, and significant investments in digital health innovation and R&D for diabetes management.
Latin America
XX.X% CAGR
US$ XX.X Mn
XX.X% share
- An emerging market with increasing awareness and adoption of digital therapeutics, driven by efforts to enhance chronic disease management and bridge healthcare access gaps in underserved areas.
Europe
XX.X% CAGR
US$ XX.X Mn
XX.X% share
- A mature market driven by strong public healthcare systems and increasing regulatory frameworks supporting digital therapeutics, despite some challenges from fragmented national healthcare policies.
Asia Pacific
XX.X% CAGR
US$ XX.X Mn
XX.X% share
- Witnessing rapid growth fueled by a large diabetic population, improving digital literacy, and government initiatives aimed at expanding access to advanced healthcare solutions across diverse geographies.
Middle East & Africa
XX.X% CAGR
US$ XX.X Mn
XX.X% share
- This region is experiencing nascent but promising growth, particularly in Gulf Cooperation Council (GCC) countries, as governments prioritize healthcare digitalization and innovation.
Country Analysis
United States and Brazil represent the largest country-level markets, with growth across the remaining countries shaped by local regulatory, infrastructure, and demand-side factors specific to each geography.
| # | Country | Market Size | CAGR | Key Driver |
|---|---|---|---|---|
| 1 | United States | US$ XX.X Mn | XX.X% | The largest market for digital therapeutics, driven by high diabetes prevalence, significant healthcare expenditure, and a strong innovation ecosystem for digital health solutions. Regulatory frameworks like FDA clearances also accelerate adoption. |
| 2 | Brazil | US$ XX.X Mn | XX.X% | A key market in Latin America due to its large population and high diabetes burden. Increasing internet and smartphone penetration, combined with a demand for accessible healthcare, fuels the growth of digital diabetes solutions. |
| 3 | Germany | US$ XX.X Mn | XX.X% | A pioneering market with its DiGA framework allowing for digital health apps to be prescribed and reimbursed, significantly boosting the adoption and integration of diabetes digital therapeutics into mainstream care. |
| 4 | China | US$ XX.X Mn | XX.X% | Represents the largest market in Asia-Pacific due to its immense population, high and growing diabetes burden, and aggressive government support for digital healthcare innovation. Telemedicine and digital health platforms are rapidly expanding. |
| 5 | Saudi Arabia | US$ XX.X Mn | XX.X% | Driven by a high prevalence of diabetes and ambitious national digital transformation initiatives like Vision 2030, which emphasize health technology adoption. Significant government investment in healthcare infrastructure further boosts market growth. |
Countries Covered (25)
United States, Canada, Mexico, Brazil, Argentina, Rest of Latin America, Germany, United Kingdom, France, Italy, Spain, Russia, Rest of Europe, China, Japan, India, South Korea, Australia, Taiwan, Malaysia, Rest of Asia Pacific, Saudi Arabia, United Arab Emirates, South Africa, Rest of Middle East & Africa
Competitive Landscape
| # | Company | Share | Key Strategy | Key Note | Key Developments | Key Products |
|---|---|---|---|---|---|---|
| 1 | Virta Health | XX.X% | Focus on reversing type 2 diabetes and other metabolic conditions through a physician-supervised, low-carbohydrate ketogenic therapy. | — | — | Virta TreatmentVirta for Type 2 DiabetesVirta for Prediabetes+1 |
| 2 | Omada Health | XX.X% | Provide integrated virtual care programs for a broad spectrum of chronic conditions, leveraging a coaching-first approach and a holistic health model. | — | — | Omada Program for DiabetesOmada Program for PrediabetesOmada Program for Hypertension+1 |
| 3 | One Drop | XX.X% | Empower individuals with chronic conditions through AI-powered personalized insights, human coaching, and connected health devices. | — | — | One Drop PremiumOne Drop ProfessionalAI-powered health predictions+1 |
| 4 | DarioHealth | XX.X% | Offer a full-spectrum, multi-chronic condition platform providing personalized digital therapeutics and connected devices for a 'whole person' approach. | — | — | Dario AppDario Blood Glucose Monitoring SystemDario Diabetes Program+1 |
| 5 | Glooko | XX.X% | Provide a universal platform for diabetes data management, integrating data from a wide array of devices for patients and clinicians globally. | — | — | Glooko PlatformDiasend by GlookoGlooko Mobile App+1 |
Market Positioning Map
Market share vs. growth outlook — bubble size is market share, bubble color is relative profitability
Companies Profiled (20)
Virta Health, Omada Health, One Drop, DarioHealth, Glooko, Twin Health, WellDoc, Better Therapeutics, Noom, Vida Health, Lark Health, Oviva, Liva Healthcare, Day Two, HealthifyMe, NutriSense, Levels Health, Signos, AmDTx, Hedia
The global Diabetes Digital Therapeutics market features a competitive landscape led by Virta Health, Omada Health, One Drop, DarioHealth, Glooko, and Twin Health, among other established and emerging players. Market participants continue to compete on product innovation, pricing strategy, geographic expansion, and strategic partnerships to strengthen their position in this evolving market.
* Market share estimates based on company revenue disclosures and public sources; undisclosed figures are marked.
Company Profiles
Virta Health
Omada Health
One Drop
DarioHealth
Glooko
Twin Health
WellDoc
Better Therapeutics
Noom
Vida Health
Lark Health
Oviva
Liva Healthcare
Day Two
HealthifyMe
NutriSense
Levels Health
Signos
AmDTx
Hedia
* Classification reflects relative market share and maturity, derived from revenue analysis and public disclosures.
Ready to Make Data-Driven Decisions?
Purchase the full report or request a custom engagement. Get analyst support, scenario modelling, and real-time dashboard access.
Recent Market Developments
Omada Health and Dexcom Announce Enhanced CGM Integration for Diabetes Management
Digital health leader Omada Health has expanded its strategic partnership with Dexcom, allowing for real-time integration of continuous glucose monitoring data directly into Omada's personalized diabetes management platform. This collaboration aims to provide users and coaches with more immediate and actionable insights, optimizing treatment plans and improving glycemic control.
Teladoc Health Unveils AI-Powered Predictive Insights for Livongo Diabetes Program
Teladoc Health has launched new AI-driven predictive analytics within its Livongo for Diabetes program, designed to anticipate potential health risks and provide proactive, personalized interventions. The new feature leverages machine learning to analyze member data, offering timely recommendations and coaching support to prevent complications.
Virta Health Secures Broader Payer Coverage Following Clinical Efficacy Studies
Virta Health announced significant progress in market access, securing new agreements with major health plans to expand coverage for its diabetes reversal program. This follows published clinical data further demonstrating the program's long-term efficacy in reducing medication dependence and improving health outcomes for type 2 diabetes patients.
DarioHealth Closes Strategic Funding Round to Accelerate Platform Expansion
DarioHealth, a prominent provider of digital therapeutics for chronic conditions including diabetes, announced the completion of a strategic funding round led by new institutional investors. The capital infusion is earmarked to accelerate product development, expand its multi-condition platform, and grow its market presence across employer and payer channels.
Report Data Parameters
| Parameter | Value |
|---|---|
| Base Year | 2025 |
| Forecast Year | 2035 |
| Historical Period | 2019–2025 |
| Market Size (Base Year) | $2.1 Bn |
| Market Size (Forecast) | $12.1 Bn |
| CAGR | 19.1% |
| Forecast Period | 2026–2035 |
| Geography | Global |
| Countries Covered | 25 Countries |
| Segments Covered | 6 Segments, 35 Sub-segments |
| Companies Profiled | 31 Companies |
Report Value
Why Choose This Report
Complete Market Size
Market sizing for the base year and a 10-year forecast across three scenarios.
Segment Analysis
Deep-dive segmentation by product, application, end-user, and technology verticals.
Country Analysis
Country-level market data for every country in the report scope, across all major regions.
Company Profiles
Profiles of the leading companies, with disclosed financials, strategy and market share.
Market Share
Detailed competitive market share analysis with trend mapping and benchmarking.
Competitive Intelligence
SWOT, Porter's Five Forces, and competitive positioning across market leaders.
Scenario Analysis
Three-scenario modelling (Base / Optimistic / Conservative) with CAGR decomposition.
Regulatory Review
Regulatory landscape, compliance requirements, and policy impact analysis by region.
Strategic Analysis · Management Insights · CXO Insights
Executive Strategic & Intelligence Report
A board-ready strategic deck built on the Diabetes Digital Therapeutics Market report: eleven chapters and an appendix, from market sizing to the board decisions, delivered as a PDF with an Excel datapack. US$3,000 per market, prepared after your order.
What to expect in the Executive Report for this market
- About 400 slides, 11 chapters and an appendix. Built on this report's own numbers, so every figure matches the report and the Excel.
- Market size and forecast to 2035. By segment, sub-segment, region and country, with conservative, base and optimistic cases.
- An analysis page after every exhibit. The key insight, ten specific points and the decision it implies for leaders, challengers, entrants and investors.
- Competitive intelligence. Shares and positioning, capability benchmark, strategies, recent moves and acquisition screening.
- Customers, technology and business models. Who buys and why, AI and technology impact, pricing, channels and go-to-market by segment.
- Risks and scenarios. Risk register, four future scenarios with signposts, and early-warning indicators with thresholds.
- Opportunities and the board decisions. Opportunity scoring, strategic options, roadmap, capability gaps, decision matrix and a 90-day plan.
- PDF, Excel datapack and PowerPoint. A bookmarked PDF, the full Excel datapack and editable infographic slides for your own decks.
US$3,000 per market · bought online, prepared after your order and emailed to you
See a full example report →Only need the headline view? Market Snapshot (PDF) + Excel Datasheet · 10–20 slide PDF + Excel
A CEO-level executive summary of the market in 10–20 slides - size and forecast, growth by segment and region, the leading countries and companies, key trends and the outlook - plus the Excel datasheet. A short executive view of this market, not the full analysis - PDF and Excel, prepared and emailed to you after your order.
Trusted by strategy teams, investors & global enterprises
What Our Clients Say
Verified reviews from enterprise clients
“The depth of analysis and quality of data is unparalleled. This report directly informed our $50M market expansion strategy and helped us prioritise the right geographies.”
VP, Corporate Strategy
Industrial manufacturing company
“Exceptional research quality. The competitive landscape section alone saved our team months of primary research effort and gave us a clear view of the opportunity.”
Director, Investment Research
Private equity firm
“We now use these reports in every planning cycle. The regional granularity, and the same numbers across the report, the dashboard and the Excel, save our team real time.”
Head of Market Intelligence
Specialty chemicals company
Frequently Asked Questions
Common questions about this report and our research
The Diabetes Digital Therapeutics market is estimated at $2.1 Bn in 2025. It is forecast to reach $12.1 Bn by 2035, indicating substantial growth over the decade.
The Diabetes Digital Therapeutics market is forecast to grow at a Compound Annual Growth Rate (CAGR) of 19.1% between 2025 and 2035. This rate reflects increasing adoption and technological advancements.
The market is segmented by Type (Prescription Digital Therapeutics, Non-Prescription Digital Therapeutics), Application (Type 1 Diabetes Management, Type 2 Diabetes Management), Technology (AI & Machine Learning, Cloud-Based Platforms), End-User (Patients & Caregivers, Hospitals & Clinics), Deployment, and Functionality.
Leading companies in this market include Virta Health, Omada Health, One Drop, DarioHealth, Glooko, Twin Health, WellDoc, Better Therapeutics, Noom, Vida Health, Lark Health, and Oviva.
The report covers market size and growth forecasts, key drivers and restraints, and detailed segmentation by Type, Application, Technology, End-User, Deployment, and Functionality. It also includes regional analysis and profiles of leading companies.
The Single User and Enterprise licences include the full PDF report, the PowerPoint (PPT), the Excel data workbook and the interactive Online Dashboard. The Online Dashboard gives online access to the snapshot and datasheet with export features, and the Market Snapshot is an executive summary in PDF with the Excel data sheet.
Yes. Request a free report preview: its scope, every chapter and what it contains, the methodology and the headline figures. The full report is a paid product.
We accept credit/debit cards (Visa, Mastercard, Amex), bank wire transfer, and purchase orders for enterprise clients. All transactions are secured with 256-bit SSL encryption.
Buy This Report
Choose the format that fits your budget
Digital delivery — all sales are final. See our Refund Policy and Terms & Conditions.
Strategic deck for this market
Executive Strategic & Intelligence Report
About 400 board-ready slides: every exhibit with its analysis and the decision it implies. Prepared for this market after your order and emailed to you.
Need to go deeper?
Intelligence services for this market
- Competitor benchmarking →
- Market entry & expansion →
- Product & growth opportunities →
- Investment & acquisition due diligence →
What's Included
Similar Reports
Mental Health Digital Therapeutics Market
$2.4 Bn in 2025 · 20.0% CAGR
AI Hospital Digital Twin Market
$1.2 Bn in 2025 · 22.0% CAGR
Digital Allergy Market
$318.1 Mn in 2025 · 12.1% CAGR
Digital Cardiology Platform Market
$2.2 Bn in 2025 · 14.2% CAGR
Digital Clinical Intelligence Market
$2.7 Bn in 2025 · 13.2% CAGR
Digital Human Twins Market
$742.2 Mn in 2025 · 27.5% CAGR
Digital Mental Health Market
$11.8 Bn in 2025 · 13.7% CAGR
Digital Mental Wellness Market
$6.3 Bn in 2025 · 11.5% CAGR